Combination Chemotherapy & Lenalidomide in Newly Diagnosed Stage II-IV Peripheral T-cell Non-Hodgkin's Lymphoma

NCT02561273 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Anaplastic Large Cell Lymphoma, ALK-Negative
Anaplastic Large Cell Lymphoma, ALK-Positive
Hepatosplenic T-Cell Lymphoma
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Stage II Angioimmunoblastic T-cell Lymphoma
Stage II Enteropathy-Associated T-Cell Lymphoma
Stage III Angioimmunoblastic T-cell Lymphoma
Stage III Enteropathy-Associated T-Cell Lymphoma
Stage IV Angioimmunoblastic T-cell Lymphoma
Stage IV Enteropathy-Associated T-Cell Lymphoma

Interventions

PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Etoposide
OTHER: Laboratory Biomarker Analysis
DRUG: Lenalidomide
PROCEDURE: Peripheral Blood Stem Cell Transplantation
DRUG: Prednisone
DRUG: Vincristine Sulfate

Sponsor

University of Nebraska

Collaborators

[object Object]